AngioDynamics Inc (ANGO)

9.04 +0.35 (+4.03%) USD  |  NASDAQ  |  Dec 26, 16:00
9.04 0.00 (0.00%) After-Hours: 16:59
More

AngioDynamics Research and Development Expense (Quarterly): 6.285M for Aug. 31, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Globus Medical Inc 35.38M
Masimo Corp 48.30M
Perspective Therapeutics Inc 12.03M
Xtant Medical Holdings Inc 0.701M
Catheter Precision Inc 0.063M